IONS: Isis Pharmaceuticals Quarterly EPS earnings growth
Ionis Pharmaceuticals (IONS) is competing in the RNA therapeutics segment, where the risk of clinical trial failures forces the company to rely on licensing agreements. Stable royalties provide a reliable financial foundation for new developments. The current quarterly EPS trend confirms that profits remain resilient against costs, while 17.60 captures the current value of the indicator, taking into account strict FDA oversight and the patent protection of its technologies.
%20Year-over-year%20earnings%20per%20one%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_IONS_-_Ionis-Pharmaceuticals_-_Year-over-year-earnings-per-one-share-growth-for-the-last-12-months "Ionis Pharmaceuticals - IONS Quarterly EPS earnings growth (period 07/04/2022 - 11/14/2026) | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company Isis Pharmaceuticals (IONS)
- market value and analyst target forecast:
- market capitalization information:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Debt to Equity Ionis Pharmaceuticals|IONS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Ionis Pharmaceuticals|IONS - Company Aggregate Debts|Debts to Book Capitalization Ionis Pharma|IONS - Company Long-Term Liabilities|Company Short-Term Debts Ionis|Quick Liquidity Indicator ionispharma.com
- earnings and valuation multiples indicators:
IONS - Net Profit|Future Profit Ionis Pharmaceuticals|IONS - Market Price to Net Income Ratio|Forward P/E Multiple Ionis Pharma|IONS - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Ionis Pharma|IONS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Ionis|IONS - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months ionispharma.com|IONS - Earnings per share growth in current year|Net earnings per share growth forecast for next year Ionis Pharmaceuticals
- revenue and sales details:
Initial company analysis:Ionis - IONS
This indicator measures the growth dynamics of earnings per share, capturing the efficiency of scaling the business into actual income. The metric allows for the separation of temporary growth spikes from a sustainable trend. In the case of Ionis Pharmaceuticals (IONS), the quarterly EPS growth rate reflects the commercial success of high-margin RNA therapeutics. Analysis of this chart helps assess the monetization of innovations aimed at suppressing toxic proteins. A stable trend confirms the long-term fundamental value of the asset.
Main competitors
Tempus AI Inc (TEM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months QGEN (Qiagen NV)|RGEN (Repligen Corp.) - Quarterly EPS earnings growth|RNA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CRSP|Quarterly EPS earnings growth genedx.com (WGS)|Year-over-year earnings per share growth for the last twelve months Ultragenyx RARE|Year-over-year earnings per one share growth for the last 12 months BEAM|SRPT - Year-over-year earnings per share growth for the last twelve months|Twist Bioscience Corp (TWST) - Year-over-year net earnings per share growth for the last 12 months|TXG: Quarterly EPS earnings growth|intelliatx.com (NTLA) - Quarterly EPS earnings growth|STOK (Stoke Therapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months BioLife Solutions Inc (BLFS)|Quarterly EPS earnings growth WVE|MAZE - Earnings per share growth in annualized terms for the last twelve months|Sionna Therapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth primemedicine.com PRME|TSHA: Year-over-year net earnings per share growth for the last 12 months|uniQure NV - Year-over-year earnings per share growth rate for the last twelve months|MGTX: Quarterly EPS earnings growth|RGNX - Year-over-year net earnings per share change for the last twelve months|SLDB (Solid Biosciences Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ocugen.com (OCGN)|Quarterly EPS earnings growth PACB|Quarterly EPS earnings growth Benitec Biopharma Inc (BNTC)|Year-over-year earnings per share growth for the last twelve months Design Pharma DSGN|Rocket Corp - Year-over-year earnings per share growth for the last twelve months|FDMT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Lexeo Therapeutics LXEO|KRRO: Quarterly EPS earnings growth|EDIT - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Silence Therapeutics Inc.|Earnings per share growth in annualized terms for the last twelve months ProQR Therapeutics NV PRQR|Year-over-year earnings per share growth for the last twelve months Codexis, Inc. (CDXS)|sangamo.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Nautilus Bio NAUT|Year-over-year net earnings per share change for the last twelve months Metagenomi Inc. (MGX)|Precision BioSciences - Quarterly EPS earnings growth|GBIO (Generation Bio Co.) - Year-over-year earnings per share growth for the last 12 months|Boundless Bio, Inc. (BOLD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months XCUR|IMNN (Imunon Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth RXi Pharmaceuticals|Quarterly EPS earnings growth MBIO|Year-over-year net earnings per share change for the last twelve months transcodetherapeutics.com|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|adnas.com (APDN) - Earnings per share growth in annualized terms for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|IPA (ImmunoPrecise Antibodies) - Year-over-year earnings per share growth for the last 12 months|OMGA: Quarterly EPS earnings growth|OMIC - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Regulus Therapeutics|syros.com (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months TBIO (Telesis Bio)|TCON (TRACON Pharmaceuticals Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
